Abstract
Cargo translocation across membranes is a crucial aspect of secretion. In conventional secretion signal peptide-equipped proteins enter the endoplasmic reticulum (ER), whereas a subset of cargo lacking signal peptides translocate into the ER–Golgi intermediate compartment (ERGIC) in a process called unconventional protein secretion (UcPS). The regulatory events at the ERGIC in UcPS are unclear. Here we reveal the involvement of ERGIC-localized small GTPases, Rab1 (Rab1A and Rab1B) and Rab2A, in regulating UcPS cargo transport via TMED10 on the ERGIC. Rab1 enhances TMED10 translocator activity, promoting cargo translocation into the ERGIC, whereas Rab2A, in collaboration with KIF5B, regulates ERGIC compartmentalization, establishing a UcPS-specific compartment. This study highlights the pivotal role of ERGIC-localized Rabs in governing cargo translocation and specifying the ERGIC’s function in UcPS.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All data are available in the main text and the supplementary materials. For more information and requests for reagents, please directly contact the corresponding authors. Plasmids and cell lines in this study are available on request. If there is a potential commercial application, we may require a payment and/or a complete material transfer agreement. Source data are provided with this paper.
Change history
24 July 2024
A Correction to this paper has been published: https://doi.org/10.1038/s41556-024-01471-2
References
Shan, S. O. & Walter, P. Co-translational protein targeting by the signal recognition particle. FEBS Lett. 579, 921–926 (2005).
Voorhees, R. M. & Hegde, R. S. Toward a structural understanding of co-translational protein translocation. Curr. Opin. Cell Biol. 41, 91–99 (2016).
Rapoport, T. A., Li, L. & Park, E. Structural and mechanistic insights into protein translocation. Annu. Rev. Cell Dev. Biol. 33, 369–390 (2017).
Zanetti, G., Pahuja, K. B., Studer, S., Shim, S. & Schekman, R. COPII and the regulation of protein sorting in mammals. Nat. Cell Biol. 14, 20–28 (2011).
Pantazopoulou, A. & Glick, B. S. A kinetic view of membrane traffic pathways can transcend the classical view of Golgi compartments. Front. Cell Dev. Biol. 7, 153 (2019).
Nickel, W. & Rabouille, C. Mechanisms of regulated unconventional protein secretion. Nat. Rev. Mol. Cell Biol. 10, 148–155 (2009).
Rabouille, C., Malhotra, V. & Nickel, W. Diversity in unconventional protein secretion. J. Cell Sci. 125, 5251–5255 (2012).
Malhotra, V. Unconventional protein secretion: an evolving mechanism. EMBO J. 32, 1660–1664 (2013).
Zhang, M. & Schekman, R. Cell biology. Unconventional secretion, unconventional solutions. Science 340, 559–561 (2013).
Rabouille, C. Pathways of unconventional protein secretion. Trends Cell Biol. 27, 230–240 (2017).
Dimou, E. & Nickel, W. Unconventional mechanisms of eukaryotic protein secretion. Curr. Biol. 28, R406–R410 (2018).
Steringer, J. P. & Nickel, W. A direct gateway into the extracellular space: unconventional secretion of FGF2 through self-sustained plasma membrane pores. Semin. Cell Dev. Biol. 83, 3–7 (2018).
Schafer, T. et al. Unconventional secretion of fibroblast growth factor 2 is mediated by direct translocation across the plasma membrane of mammalian cells. J. Biol. Chem. 279, 6244–6251 (2004).
Duran, J. M., Anjard, C., Stefan, C., Loomis, W. F. & Malhotra, V. Unconventional secretion of Acb1 is mediated by autophagosomes. J. Cell Biol. 188, 527–536 (2010).
Cruz-Garcia, D., Brouwers, N., Malhotra, V. & Curwin, A. J. Reactive oxygen species triggers unconventional secretion of antioxidants and Acb1. J. Cell Biol. 219, e201905028 (2020).
Lock, R., Kenific, C. M., Leidal, A. M., Salas, E. & Debnath, J. Autophagy-dependent production of secreted factors facilitates oncogenic RAS-driven invasion. Cancer Discov. 4, 466–479 (2014).
Villeneuve, J. et al. Unconventional secretion of FABP4 by endosomes and secretory lysosomes. J. Cell Biol. 217, 649–665 (2018).
Ejlerskov, P. et al. Tubulin polymerization-promoting protein (TPPP/p25α) promotes unconventional secretion of α-synuclein through exophagy by impairing autophagosome-lysosome fusion. J. Biol. Chem. 288, 17313–17335 (2013).
Claude-Taupin, A., Jia, J., Mudd, M. & Deretic, V. Autophagy’s secret life: secretion instead of degradation. Essays Biochem. 61, 637–647 (2017).
Zhang, M. et al. A translocation pathway for vesicle-mediated unconventional protein secretion. Cell 181, 637–652 (2020).
Zhang, M., Kenny, S. J., Ge, L., Xu, K. & Schekman, R. Translocation of interleukin-1β into a vesicle intermediate in autophagy-mediated secretion. eLife 4, e11205 (2015).
Dupont, N. et al. Autophagy-based unconventional secretory pathway for extracellular delivery of IL-1β. EMBO J. 30, 4701–4711 (2011).
Rubartelli, A., Cozzolino, F., Talio, M. & Sitia, R. A novel secretory pathway for interleukin-1-β, a protein lacking a signal sequence. EMBO J. 9, 1503–1510 (1990).
Rubartelli, A., Bajetto, A., Allavena, G., Cozzolino, F. & Sitia, R. Posttranslational regulation of interleukin-1-β secretion. Cytokine 5, 117–124 (1993).
Dirac-Svejstrup, A. B., Sumizawa, T. & Pfeffer, S. R. Identification of a GDI displacement factor that releases endosomal Rab GTPases from Rab-GDI. EMBO J. 16, 465–472 (1997).
Goody, R. S., Müller, M. P. & Wu, Y. W. Mechanisms of action of Rab proteins, key regulators of intracellular vesicular transport. Biol. Chem. 398, 565–575 (2017).
Pfeffer, S. R. Rab GTPases: master regulators that establish the secretory and endocytic pathways. Molec. Biol. Cell 28, 712–715 (2017).
Wang, X. H. et al. SMGL-1/NBAS acts as a RAB-8 GEF to regulate unconventional protein secretion. J. Cell Biol. 221, e202111125 (2022).
Li, X. X. et al. Coordination of RAB-8 and RAB-11 during unconventional protein secretion. J. Cell Biol. 223, e202306107 (2023).
Pfeffer, S. R. Rab GTPase regulation of membrane identity. Curr. Opin. Cell Biol. 25, 414–419 (2013).
Stenmark, H. Rab GTPases as coordinators of vesicle traffic. Nat. Rev. Mol. Cell Biol. 10, 513–525 (2009).
Monetta, P., Slavin, I., Romero, N. & Alvarez, C. Rab1b interacts with GBF1 and modulates both ARF1 dynamics and COPI association. Mol. Biol. Cell 18, 2400–2410 (2007).
Saraste, J. Spatial and functional aspects of ER–Golgi Rabs and tethers. Front. Cell Dev. Biol. 4, 28 (2016).
Tisdale, E. J. & Jackson, M. R. Rab2 protein enhances coatomer recruitment to pre-Golgi intermediates. J. Biol. Chem. 273, 17269–17277 (1998).
Westrate, L. M., Hoyer, M. J., Nash, M. J. & Voeltz, G. K. Vesicular and uncoated Rab1-dependent cargo carriers facilitate ER to Golgi transport. J. Cell Sci. 133, jcs239814 (2020).
Plutner, H. et al. Rab1b regulates vesicular transport between the endoplasmic reticulum and successive Golgi compartments. J. Cell Biol. 115, 31–43 (1991).
Tisdale, E. J., Bourne, J. R., Khosravifar, R., Der, C. J. & Balch, W. E. GTP-binding mutants of Rab1 and Rab2 are potent inhibitors of vesicular transport from the endoplasmic reticulum to the Golgi complex. J. Cell Biol. 119, 749–761 (1992).
Haas, A. K. et al. Analysis of GTPase-activating proteins: Rab1 and Rab43 are key Rabs required to maintain a functional Golgi complex in human cells. J. Cell Sci. 120, 2997–3010 (2007).
Sklan, E. H. et al. TBC1D20 is a Rab1 GTPase-activating protein that mediates hepatitis C virus replication. J. Biol. Chem. 282, 36354–36361 (2007).
Thomas, L. L., Joiner, A. M. N. & Fromme, J. C. The TRAPPIII complex activates the GTPase Ypt1 (Rab1) in the secretory pathway. J. Cell Biol. 217, 283–298 (2018).
Yin, J. et al. GOP-1 promotes apoptotic cell degradation by activating the small GTPase Rab2 in C. elegans. J. Cell Biol. 216, 1775–1794 (2017).
Riedel, F., Galindo, A., Muschalik, N. & Munro, S. The two TRAPP complexes of metazoans have distinct roles and act on different Rab GTPases. J. Cell Biol. 217, 601–617 (2018).
Borchers, A. C., Langemeyer, L. & Ungermann, C. Who’s in control? Principles of Rab GTPase activation in endolysosomal membrane trafficking and beyond. J. Cell Biol. 220, e202105120 (2021).
Overmeyer, J. H., Wilson, A. L. & Maltese, W. A. Membrane targeting of a Rab GTPase that fails to associate with Rab escort protein (REP) or guanine nucleotide dissociation inhibitor (GDI). J. Biol. Chem. 276, 20379–20386 (2001).
Wu, Y. W. et al. Membrane targeting mechanism of Rab GTPases elucidated by semisynthetic protein probes. Nat. Chem. Biol. 6, 534–540 (2010).
Wandinger-Ness, A. & Zerial, M. Rab proteins and the compartmentalization of the endosomal system. Cold Spring Harb. Perspect. Biol. 6, a022616 (2014).
Saraste, J. & Marie, M. Intermediate compartment (IC): from pre-Golgi vacuoles to a semi-autonomous membrane system. Histochem. Cell Biol. 150, 407–430 (2018).
Appenzeller-Herzog, C. & Hauri, H. P. The ER–Golgi intermediate compartment (ERGIC): in search of its identity and function. J. Cell Sci. 119, 2173–2183 (2006).
Strating, J. R. P. M. & Martens, G. J. M. The p24 family and selective transport processes at the ER–Golgi interface. Biol. Cell 101, 495–509 (2009).
Blum, R. et al. Intracellular localization and in vivo trafficking of p24A and p23. J. Cell Sci. 112, 537–548 (1999).
Schleinitz, A. et al. Consecutive functions of small GTPases guide HOPS-mediated tethering of late endosomes and lysosomes. Cell Rep. 42, 111969 (2023).
Tisdale, E. J., Azizi, F. & Artalejo, C. R. Rab2 utilizes glyceraldehyde-3-phosphate dehydrogenase and protein kinase Cι to associate with microtubules and to recruit dynein. J. Biol. Chem. 284, 5876–5884 (2009).
Gillingham, A. K., Sinka, R., Torres, I. L., Lilley, K. S. & Munro, S. Toward a comprehensive map of the effectors of Rab GTPases. Dev. Cell 31, 358–373 (2014).
Sweeney, H. L. & Holzbaur, E. L. F. Motor proteins. Cold Spring Harb. Perspect. Biol. 10, a021931 (2018).
Zheng, J. & Ge, L. Diverse cellular strategies for the export of leaderless proteins. Natl Sci. Open 1, 20220018 (2022).
Aizawa, M. & Fukuda, M. Small GTPase Rab2B and its specific binding protein Golgi-associated Rab2B interactor-like 4 (GARI-L4) regulate Golgi morphology. J. Biol. Chem. 290, 22250–22261 (2015).
Goud, B., Liu, S. & Storrie, B. Rab proteins as major determinants of the Golgi complex structure. Small GTPases 9, 66–75 (2018).
Gillingham, A. K., Bertram, J., Begum, F. & Munro, S. In vivo identification of GTPase interactors by mitochondrial relocalization and proximity biotinylation. eLife 8, e45916 (2019).
Fourriere, L., Jimenez, A. J., Perez, F. & Boncompain, G. The role of microtubules in secretory protein transport. J. Cell Sci. 133, jcs237016 (2020).
Granger, E., McNee, G., Allan, V. & Woodman, P. The role of the cytoskeleton and molecular motors in endosomal dynamics. Semin. Cell Dev. Biol. 31, 20–29 (2014).
Charng, W. L. et al. Drosophila Tempura, a novel protein prenyltransferase α subunit, regulates notch signaling via Rab1 and Rab11. PLoS Biol. 12, e1001777 (2014).
Wang, C. et al. Regulation of integrin β1 recycling to lipid rafts by Rab1a to promote cell migration. J. Biol. Chem. 285, 29398–29405 (2010).
Song, S., Pan, Y., Li, H. & Zhen, H. MiR-1202 exerts neuroprotective effects on OGD/R induced inflammation in HM cell by negatively regulating Rab1a involved in TLR4/NF-κB signaling pathway. Neurochem. Res. 45, 1120–1129 (2020).
Zhang, Y. et al. The GTPase Rab1 is required for NLRP3 inflammasome activation and inflammatory lung injury. J. Immunol. 202, 194–206 (2019).
Qu, Y., Franchi, L., Nunez, G. & Dubyak, G. R. Nonclassical IL-1β secretion stimulated by P2X7 receptors is dependent on inflammasome activation and correlated with exosome release in murine macrophages. J. Immunol. 179, 1913–1925 (2007).
Marie, M., Dale, H. A., Sannerud, R. & Saraste, J. The function of the intermediate compartment in pre-Golgi trafficking involves its stable connection with the centrosome. Mol. Biol. Cell 20, 4458–4470 (2009).
Bowen, A. B., Bourke, A. M., Hiester, B. G., Hanus, C. & Kennedy, M. J. Golgi-independent secretory trafficking through recycling endosomes in neuronal dendrites and spines. eLife 6, e27362 (2017).
Sannerud, R. et al. Rab1 defines a novel pathway connecting the pre-Golgi intermediate compartment with the cell periphery. Mol. Biol. Cell 17, 1514–1526 (2006).
Lamb, C. A. et al. TBC1D14 regulates autophagy via the TRAPP complex and ATG9 traffic. EMBO J. 35, 281–301 (2016).
Wang, J. et al. Ypt1/Rab1 regulates Hrr25/CK1δ kinase activity in ER–Golgi traffic and macroautophagy. J. Cell Biol. 210, 273–285 (2015).
Zoppino, F. C. M., Militello, R. D., Slavin, I., Alvarez, C. & Colombo, M. I. Autophagosome formation depends on the small GTPase Rab1 and functional ER exit sites. Traffic 11, 1246–1261 (2010).
Ponpuak, M. et al. Secretory autophagy. Curr. Opin. Cell Biol. 35, 106–116 (2015).
Yan, R., Chen, K., Wang, B. & Xu, K. SURF4-induced tubular ERGIC selectively expedites ER-to-Golgi transport. Dev. Cell 57, 512–525 (2022).
Saraste, J. & Prydz, K. Assembly and cellular exit of coronaviruses: hijacking an unconventional secretory pathway from the pre-Golgi intermediate compartment via the Golgi ribbon to the extracellular space. Cells 10, 503 (2021).
Ding, X. et al. RAB2 regulates the formation of autophagosome and autolysosome in mammalian cells. Autophagy 15, 1774–1786 (2019).
Liu, L., Zhang, M. & Ge, L. Protein translocation into the ERGIC: an upstream event of secretory autophagy. Autophagy 16, 1358–1360 (2020).
Pallotta, M. T. & Nickel, W. FGF2 and IL-1β - explorers of unconventional secretory pathways at a glance. J. Cell Sci. 133, jcs250449 (2020).
Shi, J. J. et al. Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526, 660–665 (2015).
Evavold, C. L. et al. The pore-forming protein gasdermin D regulates interleukin-1 secretion from living macrophages. Immunity 48, 35–44 (2018).
Li, S. et al. A new type of ERGIC–ERES membrane contact mediated by TMED9 and SEC12 is required for autophagosome biogenesis. Cell Res. 32, 119–138 (2022).
Ge, L., Melville, D., Zhang, M. & Schekman, R. The ER–Golgi intermediate compartment is a key membrane source for the LC3 lipidation step of autophagosome biogenesis. eLife 2, e00947 (2013).
Varadi, M. et al. AlphaFold Protein Structure Database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res. 50, D439–D444 (2022).
Jo, S., Kim, T., Iyer, V. G. & Im, W. CHARMM‐GUI: a web‐based graphical user interface for CHARMM. J. Comput. Chem. 29, 1859–1865 (2008).
Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71–73 (2017).
Abraham, M. J. et al. GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015).
Nose, S. A molecular-dynamics method for simulations in the canonical ensemble. Mol. Phys. 52, 255–268 (1984).
Hoover, W. G. Canonical dynamics: equilibrium phase-space distributions. Phys. Rev. A 31, 1695–1697 (1985).
Parrinello, M. & Rahman, A. Polymorphic transitions in single-crystals: a new molecular-dynamics method. J. Appl. Phys. 52, 7182–7190 (1981).
Humphrey, W., Dalke, A. & Schulten, K. VMD: visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996).
Acknowledgements
The work was funded by National Natural Science Foundation of China (grant numbers 92254302, 32130023 and 32225013 to L.G.; and 32370728 to M.Z.), Ministry of Science and Technology of the People’s Republic of China (grant numbers 2021YFA0804802 and 2019YFA0508602 to L.G.) and Tsinghua University Dushi Program (M.Z.), and supported by the Vanke Special Fund for Public Health and Health Discipline Development, Tsinghua University (grant numbers 2022Z82WKJ009 to L.G. and M.Z.).
Author information
Authors and Affiliations
Contributions
L.G., M.Z., Y.S. and X.T. conceived the experiments. L.G. and M.Z. supervised the project. Y.S., Y.H., L.G. and M.Z. wrote the manuscript. Y.S. and X.T. carried out the cell biology and biochemistry experiments. H.W. assisted with the in vitro translocation assay. P.C. assisted with the data processing of CLEM. X.L. performed the molecular dynamic simulation assay. R.T. and Q.S. provided the series of Rab plasmids.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Cell Biology thanks Anbing Shi and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data
Extended Data Fig. 1 Rab1A, Rab1B and Rab2A can regulate UcPS.
a, Immunofluorescence of HEK293T cells expressing GFP-ERGIC53 and TMED10-V5 with anti-Rab1A/Rab1B/Rab2A or anti-V5 antibody. Scale bar, 3 μm. b–d, IL-1β secretion in HEK293T cells transfected with mIL-1β-FLAG and GFP-tagged Rab1A (b)/Rab1B (c)/Rab2A (d) with different doses of plasmids for expression. e, IL-1β secretion in HEK293T cells co-transfected with mIL-1β-FLAG and FUGW/V5-Rab1A/1B/2A plasmids. f–h, IL-1β secretion in HEK293T cells co-transfected with mature (m) and precursor (p) IL-1β as well as GFP/GFP-Rab1A (f)/Rab1B (g)/ Rab2A (h) plasmids. *, Non-specific band. i, IL-1β secretion in HEK293T cells transfected with mIL-1β-FLAG and GFP-tagged Rab1A /Rab1B with V5-tagged Rab1B /Rab2A. Diagram showing the quantification of IL-1β secretion (mean ± SD). P values are indicated (two-tailed t test, n=3 experiments, ns: no significant difference). e–i, R1A, Rab1A; R1B, Rab1B; R2A, Rab2A. j, The expression of Rab1A/1B in HEK293T cells transfected with control shRNA (sh Ctr) or shRNA against Rab1A and Rab1B (sh Rab1A+1B) and Rab2A/2B in HEK293T cells transfected with control shRNA (sh Ctr) or shRNA against Rab2A and Rab2B (sh Rab2A+2B). k–r, IL-1β secretion in sh Ctr and sh Rab1A+1B /sh Rab2A+2B transfected with GFP or other Rabs. The data are representative of three independent experiments. Exact P values are presented in Source numerical data. Source numerical data and unprocessed blots are available in Source data.
Extended Data Fig. 2 Rab1A, Rab1B and Rab2A regulate the secretion of a series of UcPS cargoes.
a–c, ssGFP secretion in HEK293T cells co-transfected with ssGFP and BFP/BFP-Rab1A (a)/1B (b)/2A (c) plasmids with or without BFA treatment (0.5 ng/μl). *, Non-specific band. d,e, IL-6 (d)/IL-10 (e) secretion in HEK293T cells transfected with control siRNA (si Ctr) or siRNAs against Rab1A/1B/2A. f–h, ssGFP (f)/IL-6 (g)/IL-10 (h) secretion in HEK293T cells transfected with control siRNA (si Ctr) or siRNAs against Rab1A and Rab1B. i–k, Secretion of IL-18 in HEK293T cells co-transfected with IL-18-FLAG and GFP/GFP-Rab1A (i)/1B (j)/2A (k) plasmids. l–n, Secretion of IL-33 in HEK293T cells co-transfected with IL-33-FLAG and GFP/GFP-Rab1A (l)/1B (m)/2A (n) plasmids. o–q, Secretion of IL-36α in HEK293T cells co-transfected with IL-36α-FLAG and GFP/GFP-Rab1A (o)/1B (p)/2A (q) plasmids. *, Degradation band. r–t, Secretion of HSPB5-FLAG in HEK293T cells co-transfected with HSPB5-FLAG and GFP/GFP-Rab1A (r)/1B (s)/2A (t) plasmids. u–w, Secretion of Galectin-3 in HEK293T cells co-transfected with Galectin-3-FLAG and GFP/GFP-Rab1A (u)/1B (v)/2A (w) plasmids. a–w, The data are representatives of three independent experiments. R1A, Rab1A; R1B, Rab1B; R2A, Rab2A. Source unprocessed blots are available in source data.
Extended Data Fig. 3 The function of Rab1A, Rab1B and Rab2A in IL-1β secretion depends on GTP binding and geranylgeranyl modification.
a–c, IL-1β secretion in HEK293T cells expressing GFP-Rab1A (a)/Rab1B (b)/Rab2A (c) with or without co-transfection of HA-TBC1D20. The quantification of IL-1β secretion (mean ± SD) was shown in the right. P values are indicated (two-tailed t test, n=3 experiments). L, low exposure; H, high exposure. d,e, IL-1β secretion in HEK293T cells transfected with control siRNA or siRNA against mTrs130 followed by expressing GFP/GFP-Rab1A (d)/Rab1B (e). The quantification of IL-1β secretion (mean ± SD) was shown in the right. P values are indicated (two-tailed t test, n=3 experiments). f, IL-1β secretion in HEK293T cells transfected with control siRNA or siRNA against Clec16A followed by expressing GFP/GFP–Rab2A. The quantification of IL-1β secretion (mean ± SD) was shown in the right. P values are indicated (two-tailed t test, n=3 experiments). g, mIL-1β secretion in THP-1 cells with FUGW (empty) or HA-TBC1D20 expressed. *, Non-specific band. h, Galectin-3 secretion in SW620 cells with FUGW (empty) or HA-TBC1D20 expressed. *, Non-specific band. i–k, Galectin-3 secretion in SW620 cells with FUGW (empty) and Rab1A S25N (i)/Rab1B S22N (j)/Rab2A S20N (k). l, IL-1β secretion in HEK293T cells co-transfected with Rab1A/1B/2A or CC/SS mutants. g–l, The data are representatives of three independent experiments. m, The expression of GFP-Rab1A/1B/2A compared with endogenous Rab1A/1B/2A in HeLa cells. The ratio of GFP-Rabs to endogenous Rabs is shown in the right. g–m, R1A, Rab1A; R1B, Rab1B; R2A, Rab2A. n, Immunofluorescence of HeLa cells with expression of mcherry-ERGIC53 and GFP-Rab1A/1B/2A or CC/SS mutants. Scale bar, 5 μm. Exact P values are presented in Source numerical data. Source numerical data and unprocessed blots are available in Source data.
Extended Data Fig. 4 The pivotal role of Rab1 and Rab2A in TMED10-mediated UcPS.
a–c, IL-1β secretion in HEK293T cells transfected with control siRNA (si Ctr) or siRNA against TMED10 (si TM10) followed by expressing mIL-1β-FLAG and GFP/GFP-Rab1A (a)/Rab1B (b)/Rab2A (c). The quantification of IL-1β secretion is shown below (mean ± SD). P values are indicated (two-tailed t test, n=3 experiments). L, low exposure; H, high exposure. d–f, IL-1β secretion in HEK293T cells transfected with GFP-Rab1A/1B/2A alone, TMED10-V5 alone or GFP-Rab1A/1B/2A and TMED10-V5. g–i, Co-IP analysis of HEK293T cells expressing TMED10-V5 with GFP/GFP-Rab1A (g)/1B (h)/2A (i) and their mutants. d–i, The data are representatives of three independent experiments. a–i, R1A, Rab1A; R1B, Rab1B; R2A, Rab2A. Exact P values are presented in Source numerical data. Source numerical data and unprocessed blots are available in Source data.
Extended Data Fig. 5 The function of mutants of Rab1 and Rab2A in UcPS.
a, Co-IP analysis of HEK293T cells expressing TMED10-V5 with GFP/ GFP-Rab1A/T75D/ GFP-Rab1B/T72D. b, Co-IP analysis of HEK293T cells expressing TMED10-V5 with GFP/GFP–Rab2A/Y3D. c–h, Time evolution curves (c–e) and statistical averages (f–h, mean ± SD) for the nonbonded interaction energy between Rab and TMED10-CT in the wild-type (grey) and mutant (red) MD simulation systems of Rab1A (c,f), Rab1B (d,g), and Rab2A (e,h). i, Immunofluorescence of HeLa cells with expression of mcherry-ERGIC53, TMED10-V5 and GFP-Rabs. Immunofluorescence was examined with anti-V5 antibody. Scale bar, 5 μm. j,k, HeLa cells were transfected with control siRNA (si Ctr) or siRNAs against Rab1A/1B/2A followed by coexpressing mcherry-ERGIC53, TMED10-V5 and Rabs/Rab mutants. Immunofluorescence was examined with anti-V5 antibody. Scale bar, 5 μm. l,m, IL-1β secretion in HEK293T cells transfected with mIL-1β-FLAG and GFP-tagged Rab1A /Rab1B /Rab2A /their mutants. a,b,l,m, R1A, Rab1A; R1B, Rab1B; R2A, Rab2A. Source numerical data and unprocessed blots are available in Source data.
Extended Data Fig. 6 Rab1 can facilitate IL-1β enter into the TMED10-marked ERGIC.
a, Immunofluorescence of HEK293T cells with expression of GFP1-10-TMED10 alone or together with mIL-1β-3×GFP11. Immunofluorescence was examined with anti-GFP antibody. Scale bar, 3 μm. b, The gating Strategy in flow cytometry. c, The HEK293T cells expressing GFP(1–10)-TMED10 and mIL-1β/mIL-1β WY/LL-3×GFP11. Fluorescence-activated cell sorting (FACS) analysis was performed to determine the complemented GFP signal. The GFP signal was quantified (mean ± SD). P values are indicated (two-tailed t test, n=3 experiments). Immunoblot checking the expression of the indicated plasmids are shown in the right. d, Immunofluorescence of HEK293T cells with expression of mIL-1β-FLAG and mRuby2-TMED10. Immunofluorescence was examined with anti-Rab1A/1B/2A and anti-FLAG antibody. The cells were permeabilized with digitonin before fixation. Scale bar, 3 μm. e, Immunofluorescence of HeLa cells with expression of mIL-1β-FLAG and TMED10-V5 with or without BFA treatment (0.5 ng/μL). Scale bar, 5 μm. The quantification of the percentage of mIL-1β in TMED10 is shown in the right (mean ± SD). P values are indicated (two-tailed t test, n=50 cells, ns: no significant difference). f, GST-TMED10 proteoliposomes with or without T7-Rab1A were incubated with mIL-1β-FLAG alone or with the addition of GTP or GDP. Proteinase K digestion was performed to determine the amount of membrane-protected mIL-1β. g, GST-TMED10 proteoliposomes with or without T7-Rab1B were incubated with mIL-1β-FLAG alone or with the addition of GTP or GDP. Proteinase K digestion was performed to determine the amount of membrane-protected mIL-1β. h, GST-TMED10 proteoliposomes with or without T7-Rab1B were incubated with mIL-1β-FLAG or mIL-1β WY/LL-FLAG alone or with the addition of GTP. Proteinase K digestion was performed to determine the amount of membrane-protected mIL-1β. i, GST-TMED10 or GST-TMED10ΔCT proteoliposomes with or without T7-Rab1B were incubated with mIL-1β-FLAG alone or with the addition of GTP. Proteinase K digestion was performed to determine the amount of membrane-protected mIL-1β. f–i, The data are representatives of three independent experiments. Exact P values are presented in Source numerical data. Source numerical data and unprocessed blots are available in Source data.
Extended Data Fig. 7 TMED10-positive ERGIC compartment is required for UcPS.
a, SIM analysis and 3D view of GFP-ERGIC53 and TMED10-V5 in HeLa cells. Scale bar, 5 μm in overview and 2 μm in the zoomed in. b, SIM analysis of colocalization of TMED10 regions separated from ERGIC53 with GM130, SEC16, COPB2, SEC31, Rab5A, Rab7A or Rab2A. Scale bar, 5 μm in overview and 1 μm in the zoomed in. c, SIM analysis of colocalization of ssGFP with ERGIC53 or TMED10. Scale bar, 5 μm in overview and 2 μm in the zoomed in. Diagram showing the percentage of ssGFP colocalized with ERGIC53 or TMED10 per cell. P values are indicated (two-tailed t test, n=51 cells). d,e, IL-36α (d)/IL-33 (e) secretion in HEK293T cells using RUSH system. Diagram showing the quantification of secretion (mean ± SD). P values are indicated (two-tailed t test, n=3 experiments). *, Non-specific band. L, low exposure; H, high exposure. f–h, ssGFP (f)/IL-6 (g)/IL-10 (h) secretion in HEK293T cells using RUSH system. Diagram showing the quantification of secretion (mean ± SD). P values are indicated (two-tailed t test, n=3 experiments, ns, no significant difference). *, Non-specific band. i, SIM analysis of colocalization of GM130 with ERGIC53 or TMED10. Scale bar, 5 μm in overview and 2 μm in the zoomed in. Diagram showing the percentage of GM130 colocalized with ERGIC53 or TMED10 per cell. P values are indicated (two-tailed t test, n=52 cells). Exact P values are presented in Source numerical data. Source numerical data and unprocessed blots are available in Source data.
Extended Data Fig. 8 Rab2 promotes ERGIC compartmentalization positive for TMED10.
a, The HeLa cells stably expressing GFP-ERGIC53 and TMED10-V5 were transfected with BFP/BFP-Rab2A/Y3D. SIM analysis of compartmentalization of ERGIC53 and TMED10 with anti-V5 antibody. Scale bar, 5 μm in overview and 2 μm in the zoomed in. Diagram showing the percentage of TMED10 separated from ERGIC53 per cell (mean ± SD). P values are indicated (two-tailed t test, n=52 cells). b, The COS-7 cells were coexpressing GFP-ERGIC53, TMED10-V5 and BFP/BFP-Rab1A/1B/2A. Immunofluorescence and SIM analysis of compartmentalization of ERGIC53 and TMED10 with anti-V5 antibody. Scale bar, 10 μm in overview and 5 μm in the zoomed in. c,d, The HEK293T cells were expressed with GFP–Rab2A alone or together with streptavidin-ERGIC53 and SBP–TMED10ΔGOLD with or without Biotin (40 μM). Immunoblots showing IL-36α (c)/IL-33 (d) secretion. Diagram showing normalized IL-1β secretion (mean ± SD). P values are indicated (two-tailed t test, n=3 experiments). *, Non-specific band. L, low exposure; H, high exposure. e, The HEK293T cells were co-transfected with TMED10-V5 and BFP/BFP-Rab1A/1B/2A plasmids. Immunoblot showing the amounts of TMED10-V5 in the cell lysates and the ERGIC membrane fractions. The data are representative of three independent experiments. f, The HEK293T cells were transfected with control siRNA (si Ctr) or siRNAs against Rab1A/1B/2A, followed by expressing TMED10-V5. Immunoblot showing the amounts of TMED10-V5 in the cell lysates and the ERGIC membrane fractions. The data are representative of three independent experiments. e,f, R1A, Rab1A; R1B, Rab1B; R2A, Rab2A. Exact P values are presented in Source numerical data. Source numerical data and unprocessed blots are available in Source data.
Extended Data Fig. 9 ERGIC compartmentalization is dependent on microtubules.
a, Immunofluorescence and SIM analysis of GFP-ERGIC53 and Tubulin in HeLa cells with or without Nocodazole treatment (10 μM) using SPY555-tubulin. Scale bar, 5 μm. b, Immunofluorescence and SIM analysis of GFP-ERGIC53 and TMED10-V5 stably expressed in HeLa cells with or without Nocodazole treatment (10 μM) using anti-V5 antibody. Scale bar, 5 μm in overview and 1 μm in the zoomed in. Diagram showing the percentage of TMED10 separated from ERGIC53 (mean ± SD). P values are indicated (two-tailed t test, n=52 cells, ns, no significant difference). c, Secretion of mIL-1β in HEK293T cells transfected with mIL-1β-FLAG plasmid together with GFP/GFP–Rab2A plasmids with or without Nocodazole. Diagram showing the quantification of IL-1β secretion (mean ± SD). P values are indicated (two-tailed t test, n=3 experiments, ns, no significant difference). d, Immunofluorescence and SIM analysis of GFP-ERGIC53 and TMED10-V5 stably expressed in HeLa cells with or without Cytochalasin B treatment (10 μM) using anti-V5 antibody. Actin was labelled with Phalloidin. Scale bar, 5 μm in overview and 2 μm in the zoomed in. e, Immunofluorescence and SIM analysis of GFP-ERGIC53 and TMED10-V5 stably expressed in HeLa cells with or without Latrunculin A treatment (0.4 μM) using anti-V5 antibody. Actin was labelled with Phalloidin. Scale bar, 5 μm in overview and 2 μm in the zoomed in. f, Secretion of mIL-1β in HEK293T cells transfected with mIL-1β-FLAG plasmid together with GFP/GFP–Rab2A plasmids with or without Cytochalasin B (10 μM). The data are representative of three independent experiments. g, Secretion of mIL-1β in HEK293T cells transfected with mIL-1β-FLAG plasmid together with GFP/GFP–Rab2A plasmids with or without Latrunculin A (0.4 μM). f,g, The data are representative of three independent experiments. h, Immunofluorescence and SIM analysis of GFP-ERGIC53 and TMED10-V5 stably expressed in HeLa cells with or without BFA treatment (0.5 ng/μL) using anti-V5 antibody and anti-Rab1A/1B/2A antibody. Scale bar, 5 μm in overview and 2 μm in the zoomed in. Diagram showing the percentage of TMED10 in ERGIC53 (mean ± SD). P values are indicated (two-tailed t test, n=50 cells, ns, no significant difference). Exact P values are presented in Source numerical data. Source numerical data and unprocessed blots are available in Source data.
Extended Data Fig. 10 KIF5B is required for ERGIC compartmentalization.
a, The HEK293T cells stably expressing mIL-1β-HA were transfected with indicated shRNA plasmids. 72h post transfection, the cells were harvested for knockdown efficiency test by qPCR. b, Immunofluorescence and SIM analysis of endogenous KIF5B, TMED10-V5 and BFP/BFP-Rab1A/1B in HeLa cells using anti-KIF5B and anti-V5 antibody. Scale bar, 5 μm in overview and 2 μm in the zoomed in. Diagram showing the percentage of KIF5B with TMED10 (mean ± SD). P values are indicated (two-tailed t test, n=50 cells, ns, no significant difference). c, Immunofluorescence and SIM analysis of endogenous KIF5B, TMED10-V5 and BFP/BFP-Rab2A in HeLa cells transfected with control shRNA (sh Ctr) or shRNA plasmids against Rab1A/1B/2B (sh Rab1A/1B/2B) using anti-KIF5B and anti-V5 antibody. Scale bar, 5 μm in overview and 2 μm in the zoomed in. Diagram showing the percentage of KIF5B with TMED10 (mean ± SD). P values are indicated (two-tailed t test, n=50 cells, ns, no significant difference). d–f, ssGFP (d)/IL-6 (e)/IL-10 (f) secretion in HEK293T cells co-transfected with GFP/KIF5B-GFP plasmids. g–i, ssGFP (g)/IL-6 (h)/IL-10 (i) secretion in HEK293T cells co-transfected with control shRNA (Ctr) or shRNA plasmids against KIF5B (KIF5B KD). j, The HEK293T cells of WT, KIF5B KD and Rab1B KD were transfected with GFP(1–10)-TMED10 and IL-1β-GFP11. FACS analysis was performed to determine the complemented GFP signal with cells that did not have IL-1β-GFP11 expression as a negative control. Diagram showing the quantification of GFP signal (mean ± SD). P values are indicated (two-tailed t test, n=3 experiments, ns, no significant difference). Immunoblot showing the expression of the indicated proteins. k, CoIP analysis using HEK293T cells with GFP/GFP–Rab2A and endogenous KIF3B. l, CoIP analysis using HEK293T cells with TMED10-V5 and endogenous KIF5B with or without BFP-Rab2A overexpression. *, Non-specific band. d–i,k,l, The data are representative of three independent experiments. Exact P values are presented in Source numerical data. Source numerical data and unprocessed blots are available in Source data.
Supplementary information
Supplementary Table 1
Information on the siRNA, shRNA and quantitative PCR primers used in this study.
Source data
Source Data Fig. 1
Unprocessed western blots.
Source Data Fig. 1
Statistical source data.
Source Data Fig. 2
Unprocessed western blots.
Source Data Fig. 2
Statistical source data.
Source Data Fig. 3
Unprocessed western blots.
Source Data Fig. 3
Statistical source data.
Source Data Fig. 4
Unprocessed western blots.
Source Data Fig. 4
Statistical source data.
Source Data Fig. 5
Unprocessed western blots.
Source Data Fig. 5
Statistical source data.
Source Data Fig. 6
Unprocessed western blots.
Source Data Fig. 6
Statistical source data.
Source Data Fig. 7
Unprocessed western blots.
Source Data Fig. 7
Statistical source data.
Source Data Extended Data Fig. 1
Unprocessed western blots.
Source Data Extended Data Fig. 1
Statistical source data.
Source Data Extended Data Fig. 2
Unprocessed western blots.
Source Data Extended Data Fig. 3
Unprocessed western blots.
Source Data Extended Data Fig. 3
Statistical source data.
Source Data Extended Data Fig. 4
Unprocessed western blots.
Source Data Extended Data Fig. 4
Statistical source data.
Source Data Extended Data Fig. 5
Unprocessed western blots.
Source Data Extended Data Fig. 5
Statistical source data.
Source Data Extended Data Fig. 6
Unprocessed western blots.
Source Data Extended Data Fig. 6
Statistical source data.
Source Data Extended Data Fig. 7
Unprocessed western blots.
Source Data Extended Data Fig. 7
Statistical source data.
Source Data Extended Data Fig. 8
Unprocessed western blots.
Source Data Extended Data Fig. 8
Statistical source data.
Source Data Extended Data Fig. 9
Unprocessed western blots.
Source Data Extended Data Fig. 9
Statistical source data.
Source Data Extended Data Fig. 10
Unprocessed western blots.
Source Data Extended Data Fig. 10
Statistical source data.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sun, Y., Tao, X., Han, Y. et al. A dual role of ERGIC-localized Rabs in TMED10-mediated unconventional protein secretion. Nat Cell Biol 26, 1077–1092 (2024). https://doi.org/10.1038/s41556-024-01445-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41556-024-01445-4